Corkey, B. E. & Deeney, J. T. The redox communication network as a regulator of metabolism. Front. Physiol. 11, 567796 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Hopp, A. K. & Hottiger, M. O. Uncovering the invisible: mono-ADP-ribosylation moved into the spotlight. Cells 10, 680 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hottiger, M. O. et al. Progress in the function and regulation of ADP-ribosylation. Sci. Signal. 4, mr5 (2011).

PubMed  Google Scholar 

Luscher, B. et al. ADP-ribosyltransferases, an update on function and nomenclature. FEBS J. 289, 7399–7410 (2022).

Article  PubMed  Google Scholar 

Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000).

Article  CAS  PubMed  Google Scholar 

Horenstein, A. L. et al. The circular life of human CD38: from basic science to clinics and back. Molecules 25, 4844–4859 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gasparrini, M., Sorci, L. & Raffaelli, N. Enzymology of extracellular NAD metabolism. Cell. Mol. Life Sci. 78, 3317–3331 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waller, T. J. & Collins, C. A. Multifaceted roles of SARM1 in axon degeneration and signaling. Front. Cell Neurosci. 16, 958900 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wolfram-Schauerte, M. & Hofer, K. NAD-capped RNAs — a redox cofactor meets RNA. Trends Biochem. Sci. 48, 142–155 (2023).

Article  CAS  PubMed  Google Scholar 

Ziegler, M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur. J. Biochem. 267, 1550–1564 (2000).

Article  CAS  PubMed  Google Scholar 

Nam, T. S. et al. Interleukin-8 drives CD38 to form NAADP from NADP+ and NAAD in the endolysosomes to mobilize Ca2+ and effect cell migration. FASEB J. 34, 12565–12576 (2020).

Article  CAS  PubMed  Google Scholar 

Guse, A. H. Enzymology of Ca2+-mobilizing second messengers derived from NAD: from NAD glycohydrolases to (dual) NADPH oxidases. Cells 12, 675 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aarhus, R., Graeff, R. M., Dickey, D. M., Walseth, T. F. & Lee, H. C. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J. Biol. Chem. 270, 30327–30333 (1995).

Article  CAS  PubMed  Google Scholar 

Feuz, M. B., Meyer-Ficca, M. L. & Meyer, R. G. Beyond pellagra — research models and strategies addressing the enduring clinical relevance of NAD deficiency in aging and disease. Cells 12, 500 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McReynolds, M. R., Chellappa, K. & Baur, J. A. Age-related NAD+ decline. Exp. Gerontol. 134, 110888 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Breton, M. et al. Blood NAD levels are reduced in very old patients hospitalized for heart failure. Exp. Gerontol. 139, 111051 (2020).

Article  PubMed  Google Scholar 

Pirinen, E. et al. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metab. 32, 144 (2020).

Article  CAS  PubMed  Google Scholar 

Horton, J. L. et al. Mitochondrial protein hyperacetylation in the failing heart. JCI Insight 2, e84897 (2016).

PubMed  Google Scholar 

Paulionis, L., Kane, S. L. & Meckling, K. A. Vitamin status and cognitive function in a long-term care population. BMC Geriatr. 5, 16 (2005).

Article  PubMed  PubMed Central  Google Scholar 

Fang, E. F. et al. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD+/SIRT1 reduction. Cell 157, 882–896 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang, E. F. Mitophagy and NAD+ inhibit Alzheimer disease. Autophagy 15, 1112–1114 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhasin, S., Seals, D., Migaud, M., Musi, N. & Baur, J. A. Nicotinamide adenine dinucleotide in aging biology: potential applications and many unknowns. Endocr. Rev. 44, 1047–1073 (2023).

Article  PubMed  Google Scholar 

Kulkarni, C. A. & Brookes, P. S. Cellular compartmentation and the redox/nonredox functions of NAD. Antioxid. Redox Signal. 31, 623–642 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murata, M. M. et al. NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival. Mol. Biol. Cell 30, 2584–2597 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630–655 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshino, J., Baur, J. A. & Imai, S. I. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513–528 (2018).

Article  CAS  PubMed  Google Scholar 

Williams, A. C., Hill, L. J. & Ramsden, D. B. Nicotinamide, NAD(P)(H), and methyl-group homeostasis evolved and became a determinant of ageing diseases: hypotheses and lessons from pellagra. Curr. Gerontol. Geriatr. Res. 2012, 302875 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115–130 (2008).

Article  CAS  PubMed  Google Scholar 

Terakata, M. et al. Establishment of true niacin deficiency in quinolinic acid phosphoribosyltransferase knockout mice. J. Nutr. 142, 2148–2153 (2012).

Article  CAS  PubMed  Google Scholar 

Fukuwatari, T., Ohta, M., Kimtjra, N., Sasaki, R. & Shibata, K. Conversion ratio of tryptophan to niacin in Japanese women fed a purified diet conforming to the Japanese Dietary Reference Intakes. J. Nutr. Sci. Vitaminol. 50, 385–391 (2004).

Article  CAS  PubMed  Google Scholar 

Szot, J. O. et al. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder. J. Clin. Invest. 134, e174824 (2024).

Article  PubMed  PubMed Central